Search Results - "Tuneu, L"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Autochthonous cutaneous larva migrans infection in Guipúzcoa by Panés-Rodríguez, A, Piera-Tuneu, L, López-Pestaña, A, Ormaetxea-Pérez, N, Gutiérrez-Támara, P, Ibarbia-Oruezabal, S, Tuneu-Valls, A

    Published in Actas dermo-sifiliográficas (English ed.) (01-06-2016)
    “…INTRODUCTIONCutaneous larva migrans (LM) infection forms a serpiginous eruption caused by the migration of nematode helminths through the epidermis. The…”
    Get full text
    Journal Article
  2. 2

    Autochthonous Cutaneous Larva Migrans Infection in Guipúzcoa by Panés-Rodríguez, A, Piera-Tuneu, L, López-Pestaña, A, Ormaetxea-Pérez, N, Gutiérrez-Támara, P, Ibarbia-Oruezabal, S, Tuneu-Valls, A

    Published in Actas dermo-sifiliográficas (English ed.) (01-06-2016)
    “…Abstract Introduction Cutaneous larva migrans (LM) infection forms a serpiginous eruption caused by the migration of nematode helminths through the epidermis…”
    Get full text
    Journal Article
  3. 3

    Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems by Fernández-Llimós, F, Tuneu, L, Baena, M I, Garcia-Delgado, A, Faus, M J

    Published in Current pharmaceutical design (01-01-2004)
    “…Medicines are a great contribution to the rising life expectancy in XX century. But a lot of drug safety problems were reported since 1960's. More recently,…”
    Get more information
    Journal Article
  4. 4

    Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers by ESTEVEZ, Javier A, MOLTO, Jose, VALLE, Marta, TUNEU, Laura, CEDENO, Samandhy, ANTONIJOAN, Rosa M, MANGUES, Maria A, CLOTET, Bonaventura, DOMINGO, Pere, PUNTES, Montse, BARBANOJ, Manuel J

    Published in Journal of antimicrobial chemotherapy (01-08-2012)
    “…To evaluate the pharmacokinetics, tolerability and safety of 300 mg of atazanavir boosted with 100 or 50 mg of ritonavir, both once daily, at steady state…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Systematic review of the implementation and evaluation of Pharmaceutical Care in hospitalised patients(Pharmaceutical Care implementation in hospitalised patients. Systematic review) by Silva-Castro, M M, Tuneu I Valls, L, Faus, M J

    Published in Farmacia hospitalaria (01-05-2010)
    “…The persistent morbidity and mortality related to pharmaceutical treatment for hospitalised patients mean that it is necessary to identify scientific criteria…”
    Get full text
    Journal Article
  7. 7

    Revision sistemática sobre la implantación y la evaluación del seguimiento farmacoterapéutico en pacientes hospitalizados by Silva-Castro, M.M., Tuneu i Valls, L., Faus, M.J.

    Published in Farmacia hospitalaria (2010)
    “…La persistencia de la morbimortalidad relacionada con la farmacoterapia del paciente ingresado hace necesario identificar evidencia científica sobre la…”
    Get full text
    Journal Article
  8. 8

    Drug therapy follow-up in patients admitted to a Surgery Department by Silva Castro, M M, Calleja Hernández, M A, Tuneu i Valls, L, Fuentes Caparrós, B, Gutiérrez Sáinz, J, Faus Dader, M J

    Published in Farmacia hospitalaria (01-05-2004)
    “…Patients admitted to surgery departments receive multiple drugs before, during and after surgical procedures. Anti-infectious therapy, anesthetics,…”
    Get full text
    Journal Article
  9. 9